Clinical implications of gene discovery in Parkinson's disease and parkinsonism
Identifieur interne : 001D92 ( Main/Exploration ); précédent : 001D91; suivant : 001D93Clinical implications of gene discovery in Parkinson's disease and parkinsonism
Auteurs : Christian Wider [États-Unis] ; Tatiana Foroud [États-Unis] ; Zbigniew K. Wszolek [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Discoveries, Genetic Association Studies (methods), Genetic Predisposition to Disease, Genetic counseling, Humans, Intracellular Signaling Peptides and Proteins (genetics), Mutation (genetics), Nervous system diseases, Neuroprotective Agents (therapeutic use), Oncogene Proteins (genetics), Parkinson Disease (drug therapy), Parkinson Disease (etiology), Parkinson Disease (genetics), Parkinson disease, Parkinson's disease, Parkinsonian Disorders (genetics), Parkinsonism, Protein Kinases (genetics), Protein-Serine-Threonine Kinases (genetics), alpha-Synuclein (genetics), genetic counseling, genetics, parkinsonism, tau Proteins (genetics).
- MESH :
- chemical , genetics : Intracellular Signaling Peptides and Proteins, Oncogene Proteins, Protein Kinases, Protein-Serine-Threonine Kinases, alpha-Synuclein, tau Proteins.
- drug therapy : Parkinson Disease.
- etiology : Parkinson Disease.
- genetics : Mutation, Parkinson Disease, Parkinsonian Disorders.
- methods : Genetic Association Studies.
- chemical , therapeutic use : Neuroprotective Agents.
- Genetic Predisposition to Disease, Humans.
Abstract
Over the past decade, major progress has been achieved in the identification of genes associated with Parkinson's disease (PD) and parkinsonism. Five genes have now been shown conclusively to play a role in PD susceptibility. Mutations in three of these genes, PRKN, PINK1, and DJ1, are important in early onset, recessively inherited PD, while mutations in LRRK2 and SNCA result in autosomal‐dominant PD. LRRK2 has emerged as the most prevalent genetic cause of PD and has been implicated in both familial and sporadic forms of disease. In addition, autosomal‐dominant dementia and Parkinsonism has been shown to be caused by mutations in the MAPT and PGRN genes. Molecular tests are now commercially available for several of these genes; however, in some of them, positive results need to be interpreted with caution until penetrance is better understood. In addition, clinical treatment of PD remains largely unaltered by the results of genetic testing. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22723
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001A88
- to stream Istex, to step Curation: 001A88
- to stream Istex, to step Checkpoint: 000A71
- to stream PubMed, to step Corpus: 001938
- to stream PubMed, to step Curation: 001938
- to stream PubMed, to step Checkpoint: 001982
- to stream Ncbi, to step Merge: 002A64
- to stream Ncbi, to step Curation: 002A64
- to stream Ncbi, to step Checkpoint: 002A64
- to stream Main, to step Merge: 002228
- to stream PascalFrancis, to step Corpus: 000B95
- to stream PascalFrancis, to step Curation: 002124
- to stream PascalFrancis, to step Checkpoint: 000B56
- to stream Main, to step Merge: 002743
- to stream Main, to step Curation: 001D92
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical implications of gene discovery in Parkinson's disease and parkinsonism</title>
<author><name sortKey="Wider, Christian" sort="Wider, Christian" uniqKey="Wider C" first="Christian" last="Wider">Christian Wider</name>
</author>
<author><name sortKey="Foroud, Tatiana" sort="Foroud, Tatiana" uniqKey="Foroud T" first="Tatiana" last="Foroud">Tatiana Foroud</name>
</author>
<author><name sortKey="Wszolek, Zbigniew K" sort="Wszolek, Zbigniew K" uniqKey="Wszolek Z" first="Zbigniew K." last="Wszolek">Zbigniew K. Wszolek</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7385497A84E2AB9CB7E5BC0769150E1F8CED3A96</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22723</idno>
<idno type="url">https://api.istex.fr/document/7385497A84E2AB9CB7E5BC0769150E1F8CED3A96/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A88</idno>
<idno type="wicri:Area/Istex/Curation">001A88</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A71</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Wider C:clinical:implications:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20187245</idno>
<idno type="wicri:Area/PubMed/Corpus">001938</idno>
<idno type="wicri:Area/PubMed/Curation">001938</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001982</idno>
<idno type="wicri:Area/Ncbi/Merge">002A64</idno>
<idno type="wicri:Area/Ncbi/Curation">002A64</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002A64</idno>
<idno type="wicri:Area/Main/Merge">002228</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0193444</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B95</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002124</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000B56</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Wider C:clinical:implications:of</idno>
<idno type="wicri:Area/Main/Merge">002743</idno>
<idno type="wicri:Area/Main/Curation">001D92</idno>
<idno type="wicri:Area/Main/Exploration">001D92</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Clinical implications of gene discovery in Parkinson's disease and parkinsonism</title>
<author><name sortKey="Wider, Christian" sort="Wider, Christian" uniqKey="Wider C" first="Christian" last="Wider">Christian Wider</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Foroud, Tatiana" sort="Foroud, Tatiana" uniqKey="Foroud T" first="Tatiana" last="Foroud">Tatiana Foroud</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana</wicri:regionArea>
<placeName><region type="state">Indiana</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wszolek, Zbigniew K" sort="Wszolek, Zbigniew K" uniqKey="Wszolek Z" first="Zbigniew K." last="Wszolek">Zbigniew K. Wszolek</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010">2010</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">S1</biblScope>
<biblScope unit="page" from="S15">S15</biblScope>
<biblScope unit="page" to="S20">S20</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">7385497A84E2AB9CB7E5BC0769150E1F8CED3A96</idno>
<idno type="DOI">10.1002/mds.22723</idno>
<idno type="ArticleID">MDS22723</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Discoveries</term>
<term>Genetic Association Studies (methods)</term>
<term>Genetic Predisposition to Disease</term>
<term>Genetic counseling</term>
<term>Humans</term>
<term>Intracellular Signaling Peptides and Proteins (genetics)</term>
<term>Mutation (genetics)</term>
<term>Nervous system diseases</term>
<term>Neuroprotective Agents (therapeutic use)</term>
<term>Oncogene Proteins (genetics)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (etiology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Parkinsonian Disorders (genetics)</term>
<term>Parkinsonism</term>
<term>Protein Kinases (genetics)</term>
<term>Protein-Serine-Threonine Kinases (genetics)</term>
<term>alpha-Synuclein (genetics)</term>
<term>genetic counseling</term>
<term>genetics</term>
<term>parkinsonism</term>
<term>tau Proteins (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Intracellular Signaling Peptides and Proteins</term>
<term>Oncogene Proteins</term>
<term>Protein Kinases</term>
<term>Protein-Serine-Threonine Kinases</term>
<term>alpha-Synuclein</term>
<term>tau Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mutation</term>
<term>Parkinson Disease</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Genetic Association Studies</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Neuroprotective Agents</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Genetic Predisposition to Disease</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Conseil génétique</term>
<term>Découverte</term>
<term>Maladie de Parkinson</term>
<term>Parkinsonisme</term>
<term>Pathologie du système nerveux</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Over the past decade, major progress has been achieved in the identification of genes associated with Parkinson's disease (PD) and parkinsonism. Five genes have now been shown conclusively to play a role in PD susceptibility. Mutations in three of these genes, PRKN, PINK1, and DJ1, are important in early onset, recessively inherited PD, while mutations in LRRK2 and SNCA result in autosomal‐dominant PD. LRRK2 has emerged as the most prevalent genetic cause of PD and has been implicated in both familial and sporadic forms of disease. In addition, autosomal‐dominant dementia and Parkinsonism has been shown to be caused by mutations in the MAPT and PGRN genes. Molecular tests are now commercially available for several of these genes; however, in some of them, positive results need to be interpreted with caution until penetrance is better understood. In addition, clinical treatment of PD remains largely unaltered by the results of genetic testing. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Floride</li>
<li>Indiana</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Wider, Christian" sort="Wider, Christian" uniqKey="Wider C" first="Christian" last="Wider">Christian Wider</name>
</region>
<name sortKey="Foroud, Tatiana" sort="Foroud, Tatiana" uniqKey="Foroud T" first="Tatiana" last="Foroud">Tatiana Foroud</name>
<name sortKey="Wszolek, Zbigniew K" sort="Wszolek, Zbigniew K" uniqKey="Wszolek Z" first="Zbigniew K." last="Wszolek">Zbigniew K. Wszolek</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D92 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D92 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:7385497A84E2AB9CB7E5BC0769150E1F8CED3A96 |texte= Clinical implications of gene discovery in Parkinson's disease and parkinsonism }}
This area was generated with Dilib version V0.6.23. |